Search Press releases Keywords From To 24 Jul 2013 U.S. FDA Arthritis Advisory Committee Votes On Cimzia® (certolizumab pegol) For Treatment of Adults with Active Axial Spondyloarthritis, Including Patients with Ankylosing Spondylitis Read More 10 Jul 2013 UCB gets access to rights for an antibody program from WILEX for non-oncology indications Read More 10 Jul 2013 UCB's Kremers Urban Pharmaceuticals Inc. receives FDA approval for extended release methylphenidate hydrochloride Read More 9 Jul 2013 Further exploring the complexities of the brain: UCB and The Lieber Institute For Brain Development to work together to discover new medicines Read More 4 Jul 2013 Acquisition of own shares (04-07) Read More 4 Jul 2013 UCB to out-license olokizumab to R-Pharm Read More Pagination First page Previous page Previous … Page 111 Page 112 Page 113 Page 114 Current page 115 Page 116 Page 117 Page 118 Page 119 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe